Introduction: Autoimmune enteropathy (AIE) is a rare cause of intractable diarrhea in infancy. A variant with onset in adulthood has recently been described. The immune mechanisms underlying AIE are unclear and the experience in the management of adult AIE is very limited. Case Report: A 19-year-old male patient with massive refractory diarrhea and significant weight loss was diagnosed with AIE. He did not improve with corticosteroid and azathioprine treatment and was then treated successfully with infliximab. The response to treatment was rapid and complete. Because of a severe life-threatening hypersensitivity reaction during the 4th infliximab dose, infliximab had to be discontinued and therapy with tacrolimus was initiated. A complete clinical remission has since been maintained. Conclusion: Both infliximab and tacrolimus may provide a therapeutic alternative in patients with adult refractory AIE.

1.
Hill SM, Milla PJ, Bottazzo GF, et al: Autoimmune enteropathy and colitis: Is there a generalised autoimmune gut disorder? Gut 1991;32:36–42.
[PubMed]
2.
Corazza GR, Biagi F, Volta U, et al: Autoimmune enteropathy and villous atrophy in adults. Lancet 1997;350:106–109.
[PubMed]
3.
Mirakian R, Richardson A, Milla PJ, et al: Protracted diarrhoea of infancy: Evidence in support of an autoimmune variant. Br Med J (Clin Res Ed) 1986;293:1132–1136.
[PubMed]
4.
Unsworth DJ, Walker-Smith JA: Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr 1985;4:375–380.
[PubMed]
5.
Carroccio A, Volta U, Di Prima L, et al: Autoimmune enteropathy and colitis in an adult patient. Dig Dis Sci 2003;48:1600–1606.
[PubMed]
6.
Bousvaros A, Leichtner AM, Book L, et al: Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology 1996;111:237–243.
[PubMed]
7.
Oliva-Hemker MM, Loeb DM, Abraham SC, et al: Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. J Pediatr Gastroenterol Nutr 2003;36:639–643.
[PubMed]
8.
Quiros-Tejeira RE, Ament ME, Vargas JH: Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil. J Pediatr Gastroenterol Nutr 2003;36:482–485.
[PubMed]
9.
Seidman EG, Lacaille F, Russo P, et al: Successful treatment of autoimmune enteropathy with cyclosporine. J Pediatr 1990;117:929–932.
[PubMed]
10.
Vanderhoof JA, Young RJ: Autoimmune enteropathy in a child: Response to infliximab therapy. J Pediatr Gastroenterol Nutr 2002;34:312–316.
[PubMed]
11.
Daum S, Sahin E, Jansen A, et al: Adult autoimmune enteropathy treated successfully with tacrolimus. Digestion 2003;68:86–90.
[PubMed]
12.
Gillett HR, Arnott ID, McIntyre M, et al: Successful infliximab treatment for steroid-refractory celiac disease: A case report. Gastroenterology 2002;122:800–805.
[PubMed]
13.
Targan SR, Hanauer SB, van Deventer SJ, et al: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 1997;337:1029–1035.
[PubMed]
14.
Mirakian R, Collins P, Bottazzo GF: Autoimmune enteropathy in adults. Lancet 1997;350:959–960.
[PubMed]
15.
Murch SH, Fertleman CR, Rodrigues C, et al: Autoimmune enteropathy with distinct mucosal features in T-cell activation deficiency: The contribution of T cells to the mucosal lesion. J Pediatr Gastroenterol Nutr 1999;28:393–399.
[PubMed]
16.
Lugering A, Schmidt M, Lugering N, et al: Infliximab induces apoptosis in monocytes from patients with chronic active Crohn’s disease by using a caspase-dependent pathway. Gastroenterology 2001;121:1145–1157.
[PubMed]
17.
ten Hove T, van Montfrans C, Peppelenbosch MP, et al: Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn’s disease. Gut 2002;50:206–211.
[PubMed]
18.
Oberhuber G, Caspary WF, Kirchner T, Borchard F, Stolte M: Empfehlungen zur Sprue-/Zöliakiediagnostik. Pathologe 2001;22:72–81.
[PubMed]
You do not currently have access to this content.